Provention Bio, Inc.

TZIELD

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / TZIELD – J9381

Manufacturer:

Provention Bio, Inc.

Name:

TZIELD

HCPCS Code Descriptor:

Injection, teplizumab-mzwv, 5 mcg

Category:

J Code

HCPCS:

J9381

NDC(s):

73650-0316-01, 73650-0316-10, 73650-0316-14

Primary Type:

Insulin

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

TZIELD is a Insulin drug manufactured by Provention Bio, Inc. and administered via the Intravenous route of administration. The J Code: J9381 is aligned to the drug TZIELD.

TZIELD belongs to the class of drugs known as monoclonal antibodies. It works by binding to the CD3 protein on T cells and can be used to delay the symptoms of a certain type of diabetes. TZIELD is manufactured by Provention Bio and is aligned to the HCPCS code J9381.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/23

HCPCS Effective Date:

7/1/23

HCPCS Short Description:

Inj teplizumab mzwv 5 mcg

Billing and Coding Guide:

https://tzieldhcp.com/pdf/tzield-coding-and-billing-guide.pdf

Patient Assistance:

Not Found